Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27526995 | 0.87 | CYP1A2 (0.55) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL28378490 | 0.84 | GAA (0.50) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL3368077 | 0.84 | ALDH1A1 (0.52) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL18306794 | 0.84 | GAA (0.52) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL27940048 | 0.84 | CYP1A2 (0.52) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL27940125 | 0.84 | CYP1A2 (0.52) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL28070789 | 0.83 | CYP1A2 (0.50) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL6329652 | 0.81 | GAA (0.52) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL11075305 | 0.80 | ALDH1A1 (0.48) | CYP1A2GAAMGAMSIMGAM2 | |
| SCHEMBL12859411 | 0.80 | CYP1A2 (0.47) | CYP1A2GAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110174819-A | Photoresist | 深圳市华星光电技术有限公司 | 2019-08-27 | — | — | CN | claimed |
| US-11939302-B2 | Compounds for the treatment of Alzheimer's disease | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2024-03-26 | — | — | US | disclosed |
| WO-2023162653-A1 | RESIST UNDERLAYER FILM FORMATION COMPOSITION | 日産化学株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023145923-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION FOR NANOIMPRINTING | 日産化学株式会社 | 2023-08-03 | — | — | WO | disclosed |
| CN-116528867-A | Compounds for the treatment of Alzheimer's disease | 艾伯塔大学理事会 | 2023-08-01 | — | — | CN | disclosed |
| US-20220119356-A1 | Compounds for the Treatment of Alzheimer's Disease | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-04-21 | — | — | US | disclosed |
| US-11034986-B1 | Comamonas testosteroni strain and use thereof for the synthesis of 5-hydroxymethyl-2-furancarboxylic acid | SOUTH CHINA UNIVERSITY OF TECHNOLOGY | 2021-06-15 | — | — | US | disclosed |
| CN-107365724-B | Comamonas testosteroni and application thereof in synthesis of 5-hydroxymethyl furoic acid | 华南理工大学 | 2020-04-28 | — | — | CN | disclosed |
| WO-2019194107-A1 | RESIN COMPOSITION | JNC株式会社 | 2019-10-10 | — | — | WO | disclosed |
| WO-2019194108-A1 | UREA-BINDING TETRAFUNCTIONAL (METH)ACRYLATE COMPOUND AND COMPOSITION CONTAINING SAME | JNC株式会社 | 2019-10-10 | — | — | WO | disclosed |
| EP-2299816-A1 | INHIBITORS OF JANUS KINASES | Merck Sharp & Dohme Corp. (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7696210-B2 | Gonadotropin releasing hormone receptor antagonists | WYETH (US) | 2010-04-13 | — | — | US | disclosed |
| WO-2009155156-A1 | INHIBITORS OF JANUS KINASES | MERCK & CO., INC. (US) | 2009-12-23 | — | — | WO | disclosed |
| EP-1758895-A1 | GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS | Wyeth a Corporation of the State of Delaware (US) | 2007-03-07 | — | — | EP | disclosed |
| US-20060019965-A1 | Gonadotropin releasing hormone receptor antagonists | WYETH (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2006009734-A1 | GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS | WYETH (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-0219923-B1 | ANTIBIOTIC DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-4851422-A | Antibiotic 2-(3-oxo-2-isoxazolidinyl)-5-oxo-2-tetrahydrofuran-carboxylates | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-25 | — | — | US | disclosed |
| EP-0219923-A1 | Antibiotic derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-04-29 | — | — | EP | disclosed |
| US-4526798-A | Mixtures of one or more C4 -C10 -n-alkanoic acids with the ethyl ester of 2-hydroxy-4-methyl pentanoic acid | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019965-A1 | Gonadotropin releasing hormone receptor antagonists | GNRHR, GHRHR, LHCGR | CYP1A2 4039/4885GAA 1721/4885MGAM 2872/4885 |
| US-20220119356-A1 | Compounds for the Treatment of Alzheimer's Disease | IAPP, GPR119, APP | CYP1A2 4364/4885GAA 74/4885MGAM 446/4885 |
| US-11939302-B2 | Compounds for the treatment of Alzheimer's disease | IAPP, GPR119, APP | CYP1A2 4364/4885GAA 74/4885MGAM 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.